Clik here to view.
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug...
HONG KONG & NEW YORK Reflection Biotechnologies Limited (“ReflectionBio”), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today...
View ArticleClik here to view.
Geneious Desktop Software to Be Renamed to Geneious Prime
AUCKLAND, New Zealand Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year....
View ArticleClik here to view.
Illumina的MiSeq™Dx系统在中国获得核准
圣迭戈 (美国商业资讯) — Illumina, Inc. (NASDAQ:ILMN)今天宣布，其MiSeq™Dx测序系统获得中国国家药品监督管理局(CNDA)核准。这是Illumina首款获得CNDA核准的下一代测序(NGS)系统。获得该核准后，Illumina现在可以向全中国的医院和其他医疗机构推广和销售MiSeqDx测序系统，用于体外诊断(IVD)检测。...
View ArticleClik here to view.
中程度の酸素過剰状態における酸素化を反映するMasimo ORi™の性能を評価した新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Anesthesia & Analgesia誌に最近掲載された研究についての知見を発表しました。オランダのフローニンゲン大学とベルギーのゲント大学の研究者らが実施した本研究では、中程度の過酸素の範囲における酸素化（100～200...
View ArticleClik here to view.
レスメドのAstral生命維持人工呼吸器が米国でAutoEPAPを搭載
サンディエゴ （ビジネスワイヤ） — クラウド接続型呼吸ケアデバイスの世界的リーダー企業であるレスメド（NYSE: RMD）（ASX: RMD）は本日、米国患者にとっての治療選択肢として大きな需要があるiVAPSでのAutoEPAPオプションを含め、当社のAstral生命維持人工呼吸器の重要なアップグレードを発表しました。...
View ArticleClik here to view.
瑞思迈Astral生命支持呼吸机现已在美国提供AutoEPAP
圣迭戈 (美国商业资讯) — 云端呼吸治疗装置的全球领先者瑞思迈(ResMed, NYSE: RMD, ASX: RMD)今天发布了其Astral生命支持呼吸机的关键升级，包括面向美国患者的iVAPS模式下AutoEPAP选项，这是一种具有很高需求的治疗选择。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
SAN FRANCISCO & BOSTON Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the...
View ArticleClik here to view.
Shionogi Announces U.S. Availability of Mulpleta® (Lusutrombopag) for the...
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) announced today that Mulpleta® (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin...
View ArticleClik here to view.
PolyActiva Commences Its First Phase I Clinical Trial with Potential to...
MELBOURNE, Australia PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma...
View ArticleClik here to view.
Nebula Genomics从领先的技术和生物技术风投公司筹集430万美元种子经费
旧金山和波士顿 (美国商业资讯) — Nebula Genomics今天宣布已从10家领先的风投公司筹集430万美元种子经费。该经费将支持公司的使命，即创建一个值得信赖的、安全的、去中央化基因组数据市场，引领个人基因组测序的纪元。公司同时已与领先的全基因组测序和解读公司Veritas Genetics铸就伙伴关系，后者将把Nebula市场与Veritas的Arvados开源软件平台联接起来。...
View ArticleClik here to view.
NanOlogy™发布吸入NanoPac治疗肺癌的阳性临床前数据
德克萨斯州沃思堡和达拉斯 (美国商业资讯) — 临床阶段药品开发公司NanOlogy LLC呈报了吸入NanoPac™（亚微米颗粒紫杉醇）的临床前研究数据，非小细胞肺癌(NSCLC)原位动物模型显示，药物在肺组织中的驻留时间延长，肿瘤消退显著，未观察到药物相关的不良反应。在6月召开的ASCO 2018年会期间，该数据以摘要形式呈报，题为“NanoPac吸入治疗裸鼠原位肺癌模型的NSCLC”。...
View ArticleClik here to view.
SanBio: Acquisition of a Patent Portfolio Regarding Cell Medicines Derived...
TOKYO The SanBio Group, a scientific leader in regenerative medicine for neurological disorders, today announced the acquisition of a patent portfolio regarding cell medicines derived from...
View ArticleClik here to view.
NovellusDx and Primetech Sign an Exclusive Dealer Agreement in Japan
TOKYO & JERUSALEM NovellusDx, Ltd. (CEO: Haim Gil-Ad, headquarters: Jerusalem Bio-Park, Hadassah medical center, Ein-Kerem Campus, Israel) and Primetech Co., Ltd. (President: Ryosuke Ogihara,...
View ArticleClik here to view.
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel...
INGELHEIM, Germany & BEIJING, China Boehringer Ingelheim and Tsinghua University in Beijing announce a collaboration aiming to research and develop immunological therapies for infectious...
View ArticleClik here to view.
Shionogi Announces Upcoming Presentations from Symproic® (naldemedine)...
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) will present four scientific posters featuring pre-clinical and clinical findings of Symproic® (naldemedine)...
View ArticleClik here to view.
Otsuka Pharmaceutical Completes Acquisition of Visterra
WALTHAM, Mass. Visterra, Inc. (Visterra) announces that Otsuka Pharmaceutical Co., Ltd. of Japan has completed the acquisition of Visterra for approximately USD 430 million in an all-cash...
View ArticleClik here to view.
ネビュラ・ゲノミクスが大手テクノロジー／バイオテクノロジーベンチャーキャピタルからシードファイナンスで430万ドルを調達
サンフランシスコ & ボストン （ビジネスワイヤ） —...
View ArticleClik here to view.
Celltrion Healthcare: UK Lags behind Most of Europe in Access to Biologics...
MANCHESTER, England Celltrion Healthcare calls for the NHS to consider lowering the threshold for starting biologics in patients with rheumatoid arthritis (RA) and to put plans in place to increase...
View ArticleClik here to view.
New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy,...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared...
View ArticleClik here to view.
新研究比较两种指导目标导向补液治疗的方法：无创Masimo PVi®和侵入性食管多普勒超声
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，《BMC麻醉学》(BMC Anesthesiology)最新发表了瑞典林彻平大学医院的一项研究成果，研究人员比较了两种目标导向补液治疗(GDFT)方法对开腹大手术患者的功效，一是采用侵入性食管多普勒超声，另一种是采用Masimo...
View Article